Invitrogen™ Peptide synthétique LGI1 humain
LGI1 Synthetic Peptide, PEP-0626, from Invitrogen.
- Gene ID (Entrez)
- 9211
- Espèces
- Human
- Méthode de purification
- purified
- Numéro d’adhésion
- O95970
- Nom usuel
- Human LGI1
- Marque
- Invitrogen
LGI1 Synthetic Peptide, PEP-0626, from Invitrogen.
LGI1 Synthetic Peptide, PEP-0626, from Invitrogen.
The leucine-rich, glioma inactivated gene 1 (LGI1) was first identified as a candidate tumor suppressor gene for glioma and may play a role in other cancers. LGI1 is a member of a family of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 serves as a ligand to ADAM22, a metalloprotease localized at the synapse. Mutations in LGI1 account for nearly half of autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Two isoforms of LGI1 are known to exist.
Espèces : Humaine.
Conservation : -20°C.
Concentration : 200 μg/mL.
Réservé à la recherche (RUO).
Conditionnement : 50 μg.
| Général | |
|---|---|
| Marque | Invitrogen |
| Réf. fournisseur (Fisher Scientific) | 15318800 |
| Caractéristiques | |
| Gene ID (Entrez) | 9211 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | O95970 |
| Nom usuel | Human LGI1 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | LGI1 |
| Lyophilisé | No |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Stockage et expédition | |
| Contenu et stockage | -20°C |
| Conservateur | 0.02% sodium azide |
| Tampon de stockage | PBS |
| Réf. fabricant | PEP-0626 |
|---|---|
| Pays d’origine | États-Unis |
| Code douanier (SH) | 3824 99 92 00 |